TrialClinical trialPHN-02582026-04-29 19:00 CT
A Study to Test Whether Survodutide Helps Japanese People Living With Obesity Disease
Source · ClinicalTrials.gov: survodutide
TLDR
ClinicalTrials.gov lists as completed a study testing survodutide (BI 456906) for weight loss in Japanese adults with obesity disease. Participants were randomly assigned to two survodutide groups or a placebo group; the provided excerpt does not report results.
01—Key points
- 01Eligibility included adults with specified BMI thresholds and weight-related health problems who had not lost weight through dietary changes.
- 02All groups received counselling on diet and exercise alongside the study treatment.
- 03The study planned regular body-weight measurements and monitoring of health and unwanted effects over about 1 year and 7 months.
Why it matters Editorial
The completed study addresses survodutide’s effects on weight and safety in Japanese adults with obesity disease, but the excerpt provides no outcome data.
Summary generated with AI and reviewed by an editor. The original source governs; summaries can contain errors. Information only — not medical advice. Full disclaimer.
No related news yet.